Thromboelastometry and a hemostasis management system are most beneficial for guiding hemostatic therapy in cardiac surgery patients with a EuroSCORE Ⅱ of ≥1.83% : a randomized controlled two-step trial

この論文をさがす

収録刊行物

詳細情報 詳細情報について

問題の指摘

ページトップへ